(No ratings)
Dr. Minggui Pan, PhD, MD is a medical oncologist in Palo Alto, CA specializing in medical oncology and adult oncology. He graduated from Fujian Medical University. Dr. Minggui Pan, PhD, MD is affiliated with Stanford Health Care.
Dr. Minggui Pan, PhD, MD graduated from Fujian Medical University. He completed residency at University of California, San Francisco (UCSF) Affiliated Hospitals. He is certified by the American Board of Internal Medicine, Medical Oncology and has a state license in California.
Medical School: Fujian Medical University
Residency: University of California, San Francisco (UCSF) Affiliated Hospitals
Board Certification: American Board of Internal Medicine, Medical Oncology
Licensed In: California
Dr. Minggui Pan, PhD, MD is associated with these hospitals and organizations:
Dr. Minggui Pan, PhD, MD does not have any reviews yet, be the first to leave a review of Dr. Minggui Pan, PhD, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Minggui Pan, PhD, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Aadi Bioscience, Inc. |
$2,994
FYARRO $2,994 |
|
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. |
$2,900
Gilotrif $2,900 |
|
| Rigel Pharmaceuticals, Inc. |
$141
Tavalisse $141 |
|
| Exelixis Inc. |
$125
Cabometyx $125 |
|
| Pfizer Inc. |
$124
XALKORI $124 |
|
| Other |
$235
TECENTRIQ $36 |
$199 |
| Consulting Fee | $2,900 |
|---|---|
| Honoraria | $2,760 |
| Food and Beverage | $859 |
Dr. Minggui Pan, PhD, MD has received 3 research payments totaling $41,888.
Dr. Ming-Gui Pan specializes in adult oncology and medical oncology and practices in Santa Clara, CA and Palo Alto, CA. He is a graduate of Fujian Medical University. He trained at a hospital affiliated with the University of California, San Francisco (UCSF) for his residency. Dr. Pan's clinical interests encompass immunotherapy, chemotherapy, and soft tissue sarcoma. He has received distinctions including Asian Pacific Heritage Award, Kaiser Permanente; Fellow of Lymphoma Research, Lymphoma Research Foundation of America; and Merit Award, American Society of Clinical Oncology. Dr. Pan is conversant in Mandarin and Taiwanese. He is professionally affiliated with Stanford Health Care.